Talon Biomarkers
A Biomarker Discovery Engine
health AIbiomarker discoveryimmunologytranslational research
Founded2021
Employees6
LocationWhippany, NJ
About
Talon Biomarkers is a biomarker discovery engine built to capture indicators of disease and therapy from a sea of immune cells. We're fueled by a uniquely powerful and robust technology platform that changes the old-school paradigm of how a contract-research organization works. We are your partners in science, helping with experimental and study design, data acquisition, analysis, and even interpretation of results. We have strategic partnerships with influential and cutting-edge companies in the single cell, immuno-oncology, and immunoassay spaces, coupled with the expertise and creativity to realize your study goals!
Product
- Value proposition
- Supports analysis of cells, plasma, and tissues across research studies and clinical trials with workflow from study design through execution and data interpretation to deliver immune analyses aligned with biological questions and downstream decisions.
- Target customers
- Researchers in pharma/biotech, academic labs, CROs
Founders
- Dr. Pratip Chattopadhyay — Founder and CEO
- Arielle Ginsberg — Co-founder and Chief Commercial Officer
Products
Biomarker discovery platformImmune profilingData analyticsConsultation and support services
Key features
Integrated immune profiling across modalitiesQuestion-driven study design and analysisContextualized, interpretable resultsScalable workflows from discovery to translational studiesDecision-ready insights tied to development strategyProprietary search tool for research-backed biomarkers
Technologies
immune profilingdata analyticsbiomarker discoverytranslational researchlongitudinal studiesclinical trials
Traction metrics
Supports analysis of cells, plasma, and tissues across studies and trialsAlignment of analyses with biological questions and downstream decisionsFrom goal to answer design methodology
News
- LASE Innovation and Talon Biomarkers Launch First-of-its-Kind Service to Unlock TCell Activation Kinetics at Single-Cell Resolution - LASE Innovation · 2025-08-14T19:08:15.000Z
- 41 NJ-Based Startups Awarded $3M from CSIT · 2024-10-16T00:00:00.000Z
- Talon Biomarkers 2026: Innovative Disease Research Initiatives | Pratip Chattopadhyay posted on the topic | LinkedIn · 2026-01-12T20:08:46.000Z
- LASE Innovation Appoints Dr. Yulia Shulga as Principal Scientist ... · 2024-07-24T00:00:00.000Z
- LASE Innovation: Home · 2025-08-13T00:00:00.000Z
- Cure Member Spotlight: Gilead Kedem, MD · 2026-01-08T00:00:00.000Z
Browse similar startups
Related startups
- TheMothershp — Bloomfield, NJ
- Trials.ai by ZS — Princeton, NJ
- Vior Health — Toms River, NJ
- WellWink Health — Hackensack, NJ
- Xenon Ophthalmics — Jersey City, NJ
- Apex Remote Monitoring — South Plainfield, NJ
- TaskferHealth — Atlanta, GA
- Taylor Elder Care Management — Sebastopol, CA
- TECLens — Stamford, CT
- Texas Cancer Institute — Austin, TX
- Texas Cancer Specialists — Fort Worth, TX
- The Broadway Elder Living and Rehabilitation — Lockport, LA
Profile updated Jul 29, 2026. Sources: talonbiomarkers.com
